Patients with grade 2/3 hypertension were randomized to receive telmisartan 40 mg ( T40 ) / hydrochlorothiazide 12.5 mg ( H12 .5 ) combination or T40 monotherapy for one week , before uptitrating the dose to T80/H25 or T80 , respectively , for the remaining 6 weeks .